Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
The U.S. plans to make it easier for gay and bisexual men to give blood by easing restrictions on groups that typically face higher risks of HIV.
Five former Memphis police officers were charged with murder in the death of Tyre Nichols, the FDA explores yearly COVID vaccines, and New York City explores electric Uber and Lyft rides. Here is everything you Need2Know for Friday, January 27, 2023.
The Food and Drug Administration is joining an international probe that is taking a closer look at some cough syrups that have killed over 300 children worldwide.
Payam Banazadeh, founder and CEO of Capella Space, joined Cheddar News to discuss the satellite imagery company's latest $60 million funding and what government projects lie ahead.
Ants could be the next line of defense against cancer, according to a study.
The Food and Drug Administration is meeting on Thursday to plan a long-term strategy for Covid-19.
A study shows ants could be key to detecting human cancer.
GenBioPro, an abortion pill maker, is suing West Virginia over its abortion ban.
A surge in COVID-19 infections overseas in places like China has prompted the U.S. Centers for Disease and Control to consider testing airplane wastewater for the virus.
A new study shows that ants may be able to detect human cancer with their highly-developed sense of smell.
